Related Articles
Outpatient therapy with irinotecan and low-dose cisplatin for metastatic colorectal cancer resistant to 5-fluorouracil
DOUBLE-MODULATION OF 5-FLUOROURACIL BY METHOTREXATE AND LEUCOVORIN IN ADVANCED COLORECTAL-CARCINOMA
Irinotecan combined or alternated with bolus 5-fluorouracil and folinic acid versus the Mayo Clinic regimen in the first-line therapy of advanced colorectal cancer
Phase II trial of cisplatin, 5-fluorouracil and folinic acid using a weekly 24-h infusion schedule for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
Effects of PALA on the pharmacokinetics of 5-fluorouracil.